<i>Candida</i> chorioamnionitis: Report of two cases and review of literature

Garcia-Flores, Jose; Cruceyra, Mireia; Cañamares, Marina; Garicano, Ainhoa; Nieto, Olga; Tamarit, I.

doi:10.1080/01443615.2016.1196479

Cited by 13 publications

(10 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Candida chorioamnionitis has been reported, but it is a very rare event and usually related to procedures such as in vitro fertilization, cérclage, or amniocentesis [20].…”

Section: Complicationsmentioning

confidence: 99%

Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva

Vieira‐Baptista

Bornstein

2019

Vulvar Disease

View full text Add to dashboard Cite

“…Candida chorioamnionitis has been reported, but it is a very rare event and usually related to procedures such as in vitro fertilization, cérclage, or amniocentesis [20].…”

Section: Complicationsmentioning

confidence: 99%

Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva

Vieira‐Baptista

Bornstein

2019

Vulvar Disease

View full text Add to dashboard Cite

“…We identified 123 cases (102 singletons [ 4 , 8 – 76 ]/21 twins [ 49 , 62 , 69 , 77 – 90 ]) with Candida chorioamnionitis, including our nine cases for whom adequate maternal clinical data were available.…”

Section: Resultsmentioning

confidence: 99%

“…Antenatal treatment was conducted in 13 cases, including four of the twins ( Table 5 ) [ 41 , 44 , 64 , 71 , 73 – 76 , 81 , 87 – 89 ]. All the cases were diagnosed using amniotic fluid culture obtained through transabdominal amniocentesis at a median gestational age of 22 weeks (range, 19–26 weeks).…”

Section: Resultsmentioning

confidence: 99%

“…The advantages of amphotericin B include that it crosses the placenta, has no reported adverse effects in humans [ 97 ], and is generally effective against C. glabrata . One case report showed that intravenous amphotericin B treatment resulted in pregnancy extension by 4 weeks and the delivery of live infants with no signs of inflammatory changes in the placenta or umbilical cord [ 89 ], although three other cases resulted in stillbirth [ 76 , 87 , 88 ]. Micafungin was used in one case, although its efficacy and safety in pregnant women are unclear, and whether it crosses the placenta remains unknown.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

CandidaChorioamnionitis Leads to Preterm Birth and Adverse Fetal-Neonatal Outcome

Maki

Fujisaki

Sato

et al. 2017

Infectious Diseases in Obstetrics and Gynecology

View full text Add to dashboard Cite

Candida chorioamnionitis is rare but can lead to neonatal infection, high mortality, and neurodevelopmental impairment. We aimed to investigate maternal clinical features and perinatal outcomes and discuss future management strategies. We reviewed the medical records of women with Candida chorioamnionitis at our hospital over a 10-year period (n = 9) and previous published case reports and case series. The most prevalent Candida species was C. albicans (71.3% of the all cases). The most prevalent predisposing condition was preterm premature rupture of membranes (31/123, 25.2%), followed by pregnancy with a retained intrauterine contraceptive device (26/123, 21.1%) and pregnancy after in vitro fertilization (25/123, 20.3%). Preterm labor was the most common symptom (52/123, 42.3%), and only 13% of cases involved fever. Of the infants, 27% of the singletons and 23.8% of the twins were born before 22 gestational weeks, while 60% of the singletons and 76.2% of the twins were born at 22–36 weeks. The median birth weight of the babies born after 22 weeks was 1230 g. The mortality rates of the singletons and twins born after 22 weeks of gestation in the year 2000 or later were 28.6% and 52.4%, respectively. Antenatal treatment for Candida chorioamnionitis has not been established.

show abstract

“…While several case reports of Candida chorioamnionitis have been published [ 1 , 3 , [6] , [7] , [8] ], none has been associated with late stillbirth. Most other reports have described co-existing risk factors such as IVF [ 5 , 9 ], cervical cerclage [ 4 ] or intra-uterine contraceptive devices [ 2 ], none of which was present in this case.…”

Section: Discussionmentioning

confidence: 99%

Candida chorioamnionitis associated with late stillbirth: A case report

Obermair

Bhagwanani

Caldas

et al. 2020

Case Reports in Women's Health

View full text Add to dashboard Cite

Vulvovaginal candidiasis during pregnancy is common, but serious complications, including chorioamnionitis, are infrequent. A 41-year-old woman presented at 37 weeks of gestation with reduced fetal movements, and fetal death in utero was subsequently confirmed on ultrasound. Histopathology of the cord and placenta revealed Candida infection and microabscesses on the umbilical cord. Overall, these features are suggestive of ascending infection, consistent with Candida as the causative organism. To the best of our knowledge, this is the first reported case of late stillbirth due to Candida chorioamnionitis. More research is needed to determine the mechanism whereby Candida becomes pathogenic in pregnancy. There is also no clear consensus on how to manage such patients in a subsequent pregnancy.

show abstract

Candida chorioamnionitis: Report of two cases and review of literature

Cited by 13 publications

References 9 publications

Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva

Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva

CandidaChorioamnionitis Leads to Preterm Birth and Adverse Fetal-Neonatal Outcome

Candida chorioamnionitis associated with late stillbirth: A case report

Contact Info

Product

Resources

About